LLY |
Eli Lilly and Company |
782.95B |
5.39% |
|
|
|
|
|
825.91 |
0.41% |
44.72% |
46.61% |
---|
PFE |
Pfizer Inc. |
143.71B |
5.28% |
|
|
|
|
|
25.34 |
0.52% |
37.36% |
44.94% |
---|
ABBV |
AbbVie Inc. |
370.64B |
5.22% |
|
|
|
|
|
209.52 |
2.06% |
38.39% |
56.13% |
---|
MRK |
Merck & Co., Inc. |
226.74B |
5.12% |
|
|
|
|
|
89.76 |
0.59% |
43.60% |
59.19% |
---|
BMY |
Bristol-Myers Squibb Company |
124.10B |
5.09% |
|
|
|
|
|
60.99 |
1.62% |
40.67% |
54.97% |
---|
ABT |
Abbott Laboratories |
230.06B |
5.05% |
|
|
|
|
|
132.65 |
1.40% |
31.26% |
35.94% |
---|
JNJ |
Johnson & Johnson |
399.65B |
4.83% |
|
|
|
|
|
165.84 |
1.30% |
22.40% |
34.24% |
---|
AMGN |
Amgen Inc. |
167.37B |
4.64% |
|
|
|
|
|
311.55 |
1.50% |
38.37% |
55.11% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
2.14B |
3.22% |
|
|
|
|
|
51.37 |
-0.72% |
72.63% |
34.32% |
---|
GILD |
Gilead Sciences, Inc. |
139.54B |
2.95% |
|
|
|
|
|
112.05 |
0.23% |
39.21% |
62.75% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
1.83B |
2.92% |
|
|
|
|
|
32.75 |
1.42% |
43.71% |
61.41% |
---|
LQDA |
Liquidia Corporation |
1.26B |
2.91% |
|
|
|
|
|
14.75 |
-2.25% |
66.08% |
43.96% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.54B |
2.84% |
|
|
|
|
|
124.15 |
1.00% |
31.17% |
63.22% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
1.90B |
2.79% |
|
|
|
|
|
33.19 |
0.00% |
54.28% |
59.90% |
---|
UTHR |
United Therapeutics Corporation |
13.85B |
2.77% |
|
|
|
|
|
308.27 |
0.42% |
35.09% |
79.90% |
---|
BIIB |
Biogen Inc. |
20.03B |
2.70% |
|
|
|
|
|
136.84 |
-1.11% |
43.14% |
47.62% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
68.18B |
2.69% |
|
|
|
|
|
634.23 |
-0.49% |
49.25% |
78.29% |
---|
TVTX |
Travere Therapeutics, Inc. |
1.59B |
2.69% |
|
|
|
|
|
17.92 |
-8.94% |
77.53% |
24.82% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
939.84M |
2.68% |
|
|
|
|
|
29.85 |
0.47% |
55.89% |
43.83% |
---|
VTRS |
Viatris Inc. |
10.40B |
2.65% |
|
|
|
|
|
8.71 |
0.35% |
30.87% |
77.67% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.90B |
2.64% |
|
|
|
|
|
8.38 |
1.21% |
67.35% |
84.83% |
---|
OCUL |
Ocular Therapeutix, Inc. |
1.17B |
2.63% |
|
|
|
|
|
7.33 |
-3.30% |
132.65% |
47.49% |
---|
ANIP |
ANI Pharmaceuticals, Inc. |
1.46B |
2.63% |
|
|
|
|
|
66.95 |
-0.98% |
50.20% |
66.03% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.26B |
2.62% |
|
|
|
|
|
85.97 |
1.03% |
28.23% |
64.63% |
---|
INVA |
Innoviva, Inc. |
1.14B |
2.59% |
|
|
|
|
|
18.13 |
-0.28% |
52.77% |
37.02% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
2.02B |
2.56% |
|
|
|
|
|
105.14 |
-2.30% |
51.23% |
64.05% |
---|
PRGO |
Perrigo Company plc |
3.83B |
2.55% |
|
|
|
|
|
28.04 |
-0.07% |
43.05% |
65.47% |
---|
CORT |
Corcept Therapeutics Incorporated |
12.05B |
2.52% |
|
|
|
|
|
114.22 |
109.08% |
65.42% |
37.05% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
1.38B |
2.40% |
|
|
|
|
|
28.99 |
1.97% |
55.34% |
76.60% |
---|
GERN |
Geron Corporation |
1.01B |
2.31% |
|
|
|
|
|
1.5900 |
-3.64% |
92.88% |
48.01% |
---|
AGPXX |
Invesco Government & Agency Portfolio |
|
0.14% |
|
|
|
|
|
|
|
|
|
---|